Airway inflammation and repair in asthma

Allergology International

Volumn 50, Issue 4, 2001, Pages 281-294

  Diukanovic, R ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Airway remodeling; Asthma; Eosinophils; Inflammation; Mast cells; T cells

Indexed keywords

COLLAGEN; CORTICOSTEROID;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHUS; DISEASE SEVERITY; EOSINOPHIL; HUMAN; HYPERPLASIA; LUNG ALVEOLUS EPITHELIUM; MUSCLE HYPERTROPHY; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW; SYMPTOMATOLOGY; T LYMPHOCYTE;

EID: 0035198957     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1592.2001.00229.x     Document Type: Review

References (144)

1. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry
2. Bronchial mucosal manifestations of atopy: A comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls
3. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
4. Predominant TH2like bronchoalveolar T-lymphocyte population in atopic asthma
5. Eosinophilic inflammation in asthma
6. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate
7. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness
8. Mucosal inflammation in asthma
9. Use of induced sputum cell counts to investigate airway inflammation in asthma
10. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects
11. Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum
12. Identification of activated T-lymphocytes and eosinophils in bronchial biopsies in stable atopic asthmatics
13. The relationship between airways inflammation and asthma severity
14. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects
15. Eosinophils and most cells in bronchoalveolar lavage in subjects with mild asthma: Relationship to bronchial hyperreactivity
16. Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease
17. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions
18. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma
19. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma
20. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma
21. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation
22. Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation
23. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways
24. The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung
25. Plateletactivating factor. A potent chemotactic and chemokinetic factor for human eosinophils
26. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism
27. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia
28. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines
29. Mucosal inflammation in severe glucocorticoid-dependent asthma
30. Bronchoscopic evaluation of severe asthma: Persistent inflammation associated with high dose glucocorticoids
31. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
32. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response
33. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
34. Bronchoalveolar mast cells in extrinsic asthma. A mechanism for the initiation of antigen specific bronchoconstriction
35. Mast cells in bronchoalveolar lumen of patients with bronchial asthma
36. Cellular events in the bronchi in mild asthma and after bronchial provocation
37. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators
38. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma
39. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway
40. Release of leukotrienes in patients with bronchial asthma
41. Direct evidence of a role for mast cells in the pathogenesis of antigen-induced bronchoconstriction
42. Role of leukotrienes in exercise-induced asthma: Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist
43. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma
44. 15-Lipoxygenase immunoreactivity in normal and in asthmatic airways
45. Histochemical evidence for induction of arachidonate 15-lipoxygenase in airway disease
46. Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs
47. Airway neuropeptides and asthma
48. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase
49. Identification of human lung mast cell kininogenase as tryptase and relevance of tryptase kininogenase activity
50. Mast cell proteases as mediators of vascular leakage and cell accumulation
51. Human mast cells tryptase. A mediator of eosinophil chemotaxis and degranulation
52. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression
53. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR
54. Role of tryptase in immediate cutaneous responses in allergic sheep
55. Effect of inhaled APC 366 on allergen-induced bronchoconstriction and airway hyperresponsiveness to histamine in atopic asthmatics
56. The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma
57. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines
58. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells
59. Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms
60. Dendritic cells in the lung: What is their relevance to asthma?
61. Tolerance, danger, and the extended family
62. La-positive dendritic cells form a tightly meshed network within the human airway epithelium
63. Fluctuation of the number of CD-1 (T6)-positive dendritic cells, presumably Langerhans cells, in the nasal mucosa of patients with an isolated grass-pollen allergy before, during, and after the grass-pollen season
64. Dendritic cells in normal and asthmatic airways: Expression of the alpha subunit of the high affinity immunoglobulin E receptor (Fc epsilon RI-alpha)
65. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: Downregulation by inhaled corticosteroids
66. T cell responses to the major allergen from the house dust mite Dermatophagoides pteronyssinus, antigen P1. Comparison of patients with asthma, atopic dermatitis, and perennial rhinitis
67. Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma
68. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness
69. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status
70. T lymphocyte activation in acute severe asthma
71. Local IgE production
72. Increased levels of IL-4 in CD8T cells in atopic asthma
73. Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia
74. Lung immunopathology in cases of sudden asthma death
75. Role of inflammation in nocturnal asthma
76. Alveolar tissue inflammation in asthma
77. Exacerbations of asthma without sputum eosinophilia
78. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?
79. New insights into the pathogenesis of severe corticosteroid-dependent asthma
80. Free and complexed interleukin-8 in blood and bronchial mucosa in asthma
81. Induced sputum in asthma. Comparison of asymptomatic vs. symptomatic and steroid naive vs. steroid patients
82. Changes in bronchial inflammation of steroid (GCs) dependent asthmatics
83. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes
84. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils
85. Causes of death and pathologic findings in 304 cases of bronchial asthma
86. The presence or absence of bronchial mucus in fatal asthma
87. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma
88. The pathology of asthma with special reference to changes in the bronchial mucosa
89. Tissue remodeling as a feature of persistent asthma
90. Ciliated cell damage in the bronchial epithelium of asthmatics and non-asthmatics
91. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity
92. Relationship between presence of Creola bodies and airway hyperresponsiveness in patients with bronchial asthma
93. Creola bodies and the eosinophil cationic protein in sputum in acute asthmatic attacks with respect to their clinical significance
94. Role of mast cells and basophils in asthma
95. The site of disruption of the bronchial epithelium in asthmatic and non-asthmatic subjects
96. Expression of CD44 isoforms is increased in the airway epithelium of asthmatic subjects
97. Expression of CD44 and integrins in bronchial mucosa of normal and mildly asthmatic subjects
98. Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma
99. Influence of epithelium on guinea pig airway responses to tachykinins: Role of endopeptidase and cyclooxygenase
100. Subepithelial fibrosis in the bronchi of asthmatics
101. Dexamethasone-induced increase in platelet-derived growth factor (B) mRNA in human alveolar macrophages and myelomonocytic HL60 macrophage-like cells
102. Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor
103. Cytokines of the lung
104. Release of fibroblast proliferative activity from cultured human airway epithelial cells: A role for insulin-like growth factor 1 (IGF-1)
105. The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma
106. TGF-beta stimulation and inhibition of cell proliferation: New mechanistic insights
107. Cytokine signaling in lung: Transforming growth factor-beta secretion by lung fibroblasts
108. Eosinophilassociated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma
109. Expression of laminins in the airways in various types of asthmatic patients: A morphometric study
110. Bronchial elastic fibers in normal subjects and asthmatic patients
111. Airway and lung parenchymal content of elastic fibre is not reduced in asthma
112. Elastase release from human alveolar macrophages. Comparison between smokers and nonsmokers
113. Elastin degradation by human alveolar macrophages. A prominent role of metalloproteinase activity
114. Identification of elastase in human eosinophils: Immunolocalization, isolation, and partial characterization
115. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages
116. Dexamethasone suppresses elastin gene expression in human skin fibroblasts in culture
117. The lack of distensibility of asthmatic airways
118. Lung elastic recoil and reduced airflow in clinically stable asthma
119. Hyperplasia of bronchial muscle in chronic bronchitis
120. Muscle and mucous gland size in the major bronchi of patients with chronic bronchitis, asthma, and asthmatic bronchitis
121. Increased vascularity of the bronchial mucosa in mild asthma
122. Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or inter[eukin-1 receptor antagonists
123. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells
124. Airway wall remodelling in asthma. A novel target for the development of anti-asthma drugs
125. Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression
126. Bronchial angiogenesis in severe glucocorticoid-dependent asthma
127. Vascularity in asthmatic airways: Relation to inhaled steroid dose
128. Uncomplicated asthma in adults. Comparison of CT appearance of the lungs in asthmatic and healthy subjects
129. Chest radiography and high resolution computed tomography of the lungs in asthma
130. Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction
131. A prospective study of asthma in a rural community
132. Decline of lung function in adults with bronchial asthma
133. A 15-year follow-up study of ventilatory function in adults with asthma
134. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial
135. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma
136. Airway smooth muscle and disease workshop: Epithelial mediators
137. The role of the epithelium in modulating the responses of guinea-pig trachea induced by bradykinin in vitro
138. Neutral metalloendopeptidase in human lung tissue and cultured cells
139. Neutral endopeptidase modulates neurogenic inflammation
140. Asthma as an axon reflex
141. Effect of inhaled prostaglandin E2 on allergen-induced asthma
142. Bronchoprotective role for endogenous prostaglandin E2
143. Formation of endothelin by cultured airway epithelial cells
144. Bovine bronchial epithelial cells metabolize L-arginine to L-citrulline. Possible role of nitric oxide synthase